title: [Comparative efficacy of lansoprazole and omeprazole on the intragastric pH measured over a period of 24 hours and on the basal].
abstract: OBJECTIVE
  This paper aimed at evaluating the comparative efficacy of lansoprazole and omeprazole in reducing gastric acid secretion in patients suffering from Zollinger-Ellison syndrome.
  
  
  METHODS
  Nine patients with non-resected gastrinoma(s) an previously well controlled by omeprazole (mean dosage 75 +/- 12.4 (SEM) mg/day; extremes: 20-160 mg/day) underwent 24-hour intragastric pH-metry, baseline acid output before next dosing and serum gastrin dosages, receiving their usual therapy and thereafter lansoprazole at a weight equivalent posology (mean dosage 81.6 +/- 12.5 (SEM) mg/day; extremes: 30-165 mg/day).
  
  
  RESULTS
  Lansoprazole maintained intragastric pH and basal acid output at therapeutic levels, but a discrete reacidification, that deserves confirmation on a larger group of patients, was observed between the meals.
  
  
  CONCLUSIONS
  The possible long-term benefit of this phenomenon, especially on gastrinemia and the fundic ECL-cells density and gastric bacterial content, remains to be evaluated.
authors.affiliation: Service d'Hépato-Gastroentérologie, CHU Bichat-Claude Bernard, Université Paris VII, France.
authors.forename: G
authors.initials: G
authors.lastname: Paul
authors.forename: A
authors.initials: A
authors.lastname: Ramdani
authors.forename: M
authors.initials: M
authors.lastname: Mignon
authors.forename: T
authors.initials: T
authors.lastname: Vallot
authors.forename: S
authors.initials: S
authors.lastname: Forestier
authors.forename: G
authors.initials: G
authors.lastname: Cadiot
authors.forename: P
authors.initials: P
authors.lastname: Ruszniewski
authors.forename: M
authors.initials: M
authors.lastname: Joubert-Collin
mesh_terms: D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D000328:Adult; D000368:Aged; D000897:Anti-Ulcer Agents / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D005260:Female; D005744:Gastric Acid / Q000378:metabolism*; D005753:Gastric Mucosa / Q000187:drug effects; D005755:Gastrins / Q000032:analysis; D006801:Humans; D006863:Hydrogen-Ion Concentration; D064747:Lansoprazole; D008297:Male; D008875:Middle Aged; D009853:Omeprazole / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000494:pharmacology* / Q000627:therapeutic use; D015043:Zollinger-Ellison Syndrome / Q000097:blood / Q000188:drug therapy*
chemical_list: D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D000897:Anti-Ulcer Agents; D005755:Gastrins; D064747:Lansoprazole; D009853:Omeprazole
vernacular_title: Efficacité comparée du lansoprazole et de l'oméprazole sur le pH intragastrique mesuré sur 24 heures et sur le débit acide basal chez 9 malades atteints de syndrome de Zollinger-Ellison.